Cheminformatics Engineer London

QSAR, ADMET, ML), de novo molecular design methods, and multi-parameter optimisation is also highly desirable, will programme in Python and be familiar with Cheminfo libraries RDKit, Cactvs, Schrödinger, and data sources such as ChEMBL, SureChEMBL, and PubChem. BenevolentAI is applying artificial intelligence to develop new medicines for hard to treat diseases. It is the first fully integrated AI company with pharmaceutical discovery and clinical development capabilities. BenevolentAI's technology aims to reduce the cost, decrease failure rates and increasing the speed at which medicines are delivered to patients. BenevolentAI currently employs 165 people who work in an unrivaled, cross functional environment that incorporates leading edge data scientists, computer scientists, mathematicians and drug development R&D scientists working side by side. The company is headquartered in London with further offices in New York and Belgium. BenevolentAI's research facility is located in Babraham Science Park, Cambridge (UK). The company's AI technology is being used to develop treatments to unmet patients' needs across a wide range of diseases, including Motor Neuron Disease, Parkinson's Disease, Glioblastoma and Sarcopenia.